BCL2 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human BCL2. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human BCL2. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 38 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, ccds, chembl_molecule, chembl_target, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, go, gwas, hgnc, hpo, intact, interpro, mim, mondo, orphanet, ortholog, orthologentrez, paralog, pdb, pfam, pharmgkb, pharmgkb_gene, reactome, refseq, scxa, spliceai, string_interaction, transcript, uberon, ufeature, uniprot
Generated: 2026-03-29 — For the latest data, query BioBTree directly via MCP or API.
View API calls (51)
BCL2

Section 1: Gene Identifiers

AttributeValue
HGNC IDHGNC:990
Approved SymbolBCL2
Approved NameBCL2 apoptosis regulator
Previous NamesB-cell CLL/lymphoma 2; BCL2, apoptosis regulator
AliasesBcl-2, PPP1R50
Ensembl Gene IDENSG00000171791
NCBI Entrez Gene ID596
OMIM ID151430
Locus Typeprotein-coding gene
StatusApproved
Gene GroupsBCL2 family; Protein phosphatase 1 regulatory subunits
Genomic Location
AttributeValue
Chromosome18
Cytogenetic Band18q21.33
Start Position (GRCh38)63,123,346
End Position (GRCh38)63,320,128
StrandMinus (-)
Genomic AccessionNC_000018.10
Gene Description This gene encodes an integral outer mitochondrial membrane protein that blocks the apoptotic death of some cells such as lymphocytes. Constitutive expression of BCL2, such as in the case of translocation of BCL2 to Ig heavy chain locus, is thought to be the cause of follicular lymphoma.

Section 2: Transcript Identifiers Ensembl Transcripts (Total: 9)

Transcript IDBiotypeStartEndStatus
ENST00000333681protein_coding63,123,34663,319,769MANE Select
ENST00000398117protein_coding63,123,34663,320,128
ENST00000589955protein_coding63,313,80263,318,812
ENST00000590515protein_coding63,128,21263,161,869
ENST00000678301protein_coding63,123,34663,158,238
ENST00000677227nonsense_mediated_decay63,127,77763,318,666
ENST00000677635protein_coding_CDS_not_defined63,123,34663,138,411
ENST00000678134nonsense_mediated_decay63,123,34663,318,666
ENST00000678349nonsense_mediated_decay63,123,34663,318,666
RefSeq Transcripts - Human mRNA (Reviewed)
AccessionTypeStatusMANE Select
NM_000633mRNAREVIEWEDYes (Canonical)
NM_000657mRNAREVIEWEDNo
NM_001438935mRNAREVIEWEDNo
XM_011526135mRNAPREDICTEDNo
XM_047437733mRNAPREDICTEDNo
XM_047437734mRNAPREDICTEDNo
XM_054318966mRNAPREDICTEDNo
CCDS IDs (Total: 2)
CCDS ID
CCDS11981
CCDS45882
Exons for MANE Select Transcript (ENST00000333681) - Total: 3
Exon IDStartEndStrandLength
ENSE0000284027863,319,17463,319,769-596 bp
ENSE0000123084463,318,08263,318,952-871 bp
ENSE0000131624563,123,34663,128,759-5,414 bp

Section 3: Protein Identifiers UniProt Accessions (Total: 5)

AccessionNameLengthMassStatus
P10415Apoptosis regulator Bcl-2239 aa26,266 DaCanonical (Reviewed)
A0A7I2V3S7---Unreviewed
A0A7I2V4W1---Unreviewed
A0A7I2V5Q7---Unreviewed
A0A7I2V5Q9---Unreviewed
RefSeq Protein Accessions (Human)
AccessionTypeStatusMANE Select
NP_000624proteinREVIEWEDYes
NP_000648proteinREVIEWEDNo
NP_001425864proteinREVIEWEDNo
XP_011524437predicted_proteinPREDICTEDNo
XP_047293689predicted_proteinPREDICTEDNo
XP_047293690predicted_proteinPREDICTEDNo
XP_054174941predicted_proteinPREDICTEDNo
Protein Domains & Families (Total: 11)
IDNameType
IPR002475Bcl2-likeFamily
IPR003093Bcl2_BH4Domain
IPR004725Bcl2/BclXFamily
IPR013278Apop_reg_Bcl2Family
IPR020717Bcl2_BH1_motif_CSConserved_site
IPR020726Bcl2_BH2_motif_CSConserved_site
IPR020728Bcl2_BH3_motif_CSConserved_site
IPR020731Bcl2_BH4_motif_CSConserved_site
IPR026298Bcl-2_famFamily
IPR036834Bcl-2-like_sfHomologous_superfamily
IPR046371Bcl-2_BH1-3Domain
Pfam Domains
IDDescription
PF00452Bcl-2
PF02180BH4
Protein Features (Key Regions)
RegionPositionsDescription
BH4 motif10-30BCL2 Homology 4 domain
BH3 motif93-107BCL2 Homology 3 domain
BH1 motif136-155BCL2 Homology 1 domain
BH2 motif187-202BCL2 Homology 2 domain
Transmembrane212-233Helical membrane anchor
Disordered region39-85Intrinsically disordered
Caspase-3 cleavage34-35D34 cleavage site
Post-Translational Modifications
PositionModificationKinase
Thr69PhosphothreonineMAPK8
Ser70PhosphoserineMAPK8, PKC
Ser87PhosphoserineMAPK8

Section 4: Structure Identifiers PDB Structures (Total: 55) By Method:

  • X-ray Diffraction: 49 structures
  • Solution NMR: 6 structures
PDB IDTitleMethodResolution
8HTSBcl2 in complex with S-10rX-RAY1.25 Å
6GL8Bcl-2 with novel inhibitor S55746X-RAY1.40 Å
6QGGBcl-2 with analogue of ABT-737X-RAY1.50 Å
8HTSBcl2 in complex with S-9cX-RAY1.60 Å
6O0KBCL-2 with venetoclaxX-RAY1.62 Å
9O14BCL-2 with stapled BAD BH3 peptideX-RAY1.73 Å
9O16BCL-2 R129L with BAD SAHB 4.2X-RAY1.73 Å
5VAUBcl-2 with Beclin 1 BH3 domainX-RAY1.75 Å
6O0MBCL-2 F104L with venetoclaxX-RAY1.75 Å
8VWXBcl-2 G101V/Bcl-xL ChimeraX-RAY1.77 Å
6O0PBCL-2 G101A with venetoclaxX-RAY1.80 Å
6QGKBcl-2 with THIQ-phenyl pyrazoleX-RAY1.80 Å
8HOGBcl-2 with sonrotoclaxX-RAY1.80 Å
5VAYBcl-2 with Beclin 1 T108D BH3X-RAY1.80 Å
7YA5cp1 bound BCL2/G101VX-RAY1.85 Å
4LXDBcl_2-Navitoclax AnalogX-RAY1.90 Å
8HOHBcl-2 G101V with sonrotoclaxX-RAY1.90 Å
6QG8Bcl-2 with PUMA BH3 peptideX-RAY1.90 Å
6QGJBcl-2 fragment/ABT-263 hybridX-RAY1.90 Å
9O15BCL-2 G101V with BAD SAHB 4.2X-RAY1.99 Å
6O0OBCL-2 G101V with S55746X-RAY2.00 Å
5VAXBcl-2 with Beclin 1 BH3X-RAY2.00 Å
6QGHBcl-2 with ABT-263X-RAY2.00 Å
4LVTBcl_2-Navitoclax (ABT-263)X-RAY2.05 Å
4MANBcl_2-Navitoclax Analog (Indole)X-RAY2.07 Å
7LHBBcl-2 with prodrug ABBV-167X-RAY2.07 Å
7Y90cp1 bound BCL2X-RAY2.09 Å
8VXNBcl-2/Bcl-xL Chimera/MBPX-RAY2.09 Å
2W3LChimaeric Bcl2-xL/THIQ ComplexX-RAY2.10 Å
4IEHBcl-2 with BH3 domain inhibitorX-RAY2.10 Å
5FCGBcl-2 with HBx-BH3 motifX-RAY2.10 Å
5JSNBcl2-inhibitor complexX-RAY2.10 Å
8VXMBcl-2/Bcl-xL Chimera/MBP/S55746X-RAY2.10 Å
6O0LBCL-2 G101V with venetoclaxX-RAY2.20 Å
7YB7anti-apoptotic protein BCL-2-M12X-RAY2.20 Å
5AGXBcl-2 alpha beta-1 LINEAR complexX-RAY2.24 Å
8HOIBcl-2 D103Y with sonrotoclaxX-RAY2.25 Å
8VWZBcl-2 G101V/Bcl-xL/MBP/S55746X-RAY2.33 Å
8HLNp53/BCL2 fusion (complex3)X-RAY2.35 Å
4AQ3BCL-2 with phenylacylsulfonamideX-RAY2.40 Å
6IWBDesigned protein LD3/BCL-2X-RAY2.50 Å
8HLMp53/BCL2 fusion (complex 2)X-RAY2.52 Å
8FY1PROTAC ternary complex VCB/753bX-RAY2.56 Å
8HLLp53/BCL2 fusion (complex 1)X-RAY2.62 Å
5AGWBcl-2 alpha beta-1 complexX-RAY2.70 Å
2XA0BCL-2 with BAX BH3 peptideX-RAY2.70 Å
8IQLBmf binding to pro-survival proteinsX-RAY2.96 Å
8FY2PROTAC ternary VCB/WH244/BCL-2X-RAY2.98 Å
1G5MBCL-2, Isoform 1NMR-
1GJHBCL-2, Isoform 2NMR-
1YSWBcl-2 with acyl-sulfonamide ligandNMR-
2O21Bcl-2 with acyl-sulfonamide ligandNMR-
2O22Bcl-2 with acyl-sulfonamide ligandNMR-
2O2FBcl-2 with acyl-sulfonamide ligandNMR-
8U27Bcl-2-xL with compound 35NMR-
AlphaFold Predicted Structure
IDGlobal pLDDTSequence LengthFraction Very High Confidence
AF-P10415-F174.2118560.41 (41%)

Section 5: Cross-Species Orthologs Ensembl Orthologs

SpeciesGene IDSymbolBiotype
Mouse (Mus musculus)ENSMUSG00000057329Bcl2protein_coding
Rat (Rattus norvegicus)ENSRNOG00000077679Bcl2protein_coding
Zebrafish (Danio rerio)ENSDARG00000089109bcl2bprotein_coding
Zebrafish (Danio rerio)ENSDARG00000094704bcl2aprotein_coding
Human Paralogs (BCL2 Family Members)
Gene IDSymbolBiotype
ENSG00000030110BAK1protein_coding
ENSG00000087088BAXprotein_coding
ENSG00000129473BCL2L2protein_coding
ENSG00000137875BCL2L10protein_coding
ENSG00000140379BCL2A1protein_coding
ENSG00000143384MCL1protein_coding
ENSG00000171552BCL2L1protein_coding
ENSG00000176720BOKprotein_coding

Section 6: Clinical Variants & AI Predictions ClinVar Clinical Variants (Total: 31) Classification Summary:

ClassificationCount
Pathogenic1
Likely Pathogenic2
Uncertain Significance (VUS)15
Likely Benign1
Benign2
Not Provided10
Key Pathogenic/Likely Pathogenic Variants:
ClinVar IDVariant (HGVS)ClassificationType
253425GRCh37/hg19 18q21.32-22.2 x1PathogenicCNV Loss
155128GRCh38/hg38 18q21.32-22.3 x3Likely pathogenicCNV Gain
3062371GRCh37/hg19 18q21.32-22.3 x3Likely pathogenicCNV Gain
Variants of Uncertain Significance (Sample):
ClinVar IDVariant (HGVS)Type
2255117c.338C>A (p.Ala113Asp)SNV
3133387c.458T>A (p.Phe153Tyr)SNV
3133388c.71C>T (p.Ser24Leu)SNV
3480118c.496A>T (p.Met166Leu)SNV
4201278c.236G>A (p.Gly79Asp)SNV
3823783c.448T>C (p.Phe150Leu)SNV
SpliceAI Predictions (Total: 1,722) Top 50 Predicted Splice-Altering Variants (Score ≥ 0.90):
VariantEffectDelta Score
18:63124145:A:Cacceptor_gain0.99
18:63128138:C:Tacceptor_gain0.98
18:63128138:C:CTacceptor_gain0.98
18:63124139:A:Tacceptor_gain0.97
18:63124174:T:Aacceptor_gain0.97
18:63128133:T:TCacceptor_gain0.96
18:63124133:T:Cacceptor_gain0.95
18:63124145:A:ACacceptor_gain0.95
18:63128138:C:Tacceptor_gain0.95
18:63128758:TC:Tacceptor_gain0.94
18:63128759:CC:Cacceptor_gain0.94
18:63124173:C:CAacceptor_gain0.93
18:63124172:ACT:Aacceptor_gain0.91
18:63128756:CATC:Cacceptor_gain0.90
AlphaMissense Predictions (Total: 1,543) Classification Summary:
ClassificationDescription
likely_pathogenicScore ≥ 0.564
ambiguous0.340 < Score < 0.564
likely_benignScore ≤ 0.340
Top 50 Predicted Pathogenic Missense Variants:
VariantProtein ChangeScoreClassification
18:63128647:C:TG233D0.997likely_pathogenic
18:63128648:C:GG233R0.997likely_pathogenic
18:63128674:G:TA224D0.997likely_pathogenic
18:63128660:A:GC229R0.998likely_pathogenic
18:63128662:G:TA228D0.998likely_pathogenic
18:63128665:C:TG227E0.998likely_pathogenic
18:63128666:C:GG227R0.999likely_pathogenic
18:63128666:C:TG227R0.999likely_pathogenic
18:63128656:A:TI230N0.994likely_pathogenic
18:63128668:A:TV226E0.990likely_pathogenic
18:63128671:A:CL225R0.990likely_pathogenic
18:63128642:A:CY235D0.987likely_pathogenic
18:63128644:G:TA234D0.987likely_pathogenic
18:63128663:C:GA228P0.986likely_pathogenic
18:63128653:G:TT231N0.985likely_pathogenic
18:63128650:A:CL232R0.981likely_pathogenic
18:63128650:A:GL232P0.979likely_pathogenic
18:63128650:A:TL232Q0.978likely_pathogenic
18:63128675:C:GA224P0.972likely_pathogenic
18:63128671:A:GL225P0.966likely_pathogenic
18:63128638:A:GL236P0.962likely_pathogenic
18:63128656:A:CI230S0.962likely_pathogenic
18:63128658:G:CC229W0.962likely_pathogenic
18:63128659:C:TC229Y0.961likely_pathogenic
18:63128635:C:TG237D0.940likely_pathogenic
18:63128642:A:TY235N0.932likely_pathogenic
18:63128653:G:AT231I0.930likely_pathogenic
18:63128636:C:GG237R0.929likely_pathogenic
18:63128656:A:GI230T0.918likely_pathogenic
18:63128628:C:AK239N0.910likely_pathogenic
18:63128628:C:GK239N0.910likely_pathogenic
18:63128629:T:AK239M0.895likely_pathogenic
18:63128654:T:GT231P0.886likely_pathogenic
18:63128642:A:GY235H0.869likely_pathogenic
18:63128638:A:TL236Q0.865likely_pathogenic
18:63128648:C:AG233C0.847likely_pathogenic
18:63128638:A:CL236R0.841likely_pathogenic

Section 7: Biological Pathways & Gene Ontology Reactome Pathways (Total: 8)

Pathway IDPathway Name
R-HSA-111447Activation of BAD and translocation to mitochondria
R-HSA-111453BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
R-HSA-6785807Interleukin-4 and Interleukin-13 signaling
R-HSA-844455The NLRP1 inflammasome
R-HSA-9018519Estrogen-dependent gene expression
R-HSA-9634638Estrogen-dependent nuclear events downstream of ESR-membrane signaling
R-HSA-9818030NFE2L2 regulating tumorigenic genes
R-HSA-9824594Regulation of MITF-M-dependent genes involved in apoptosis
Gene Ontology - Biological Process (Total: 100+) Top 20 GO Biological Process Terms:
GO IDTerm
GO:0006915apoptotic process
GO:0043066negative regulation of apoptotic process
GO:0043065positive regulation of apoptotic process
GO:0008630intrinsic apoptotic signaling pathway in response to DNA damage
GO:0008631intrinsic apoptotic signaling pathway in response to oxidative stress
GO:0008625extrinsic apoptotic signaling pathway via death domain receptors
GO:0001836release of cytochrome c from mitochondria
GO:0046902regulation of mitochondrial membrane permeability
GO:0051881regulation of mitochondrial membrane potential
GO:0002903negative regulation of B cell apoptotic process
GO:0043524negative regulation of neuron apoptotic process
GO:0001782B cell homeostasis
GO:0001783B cell apoptotic process
GO:0042100B cell proliferation
GO:0030890positive regulation of B cell proliferation
GO:0043029T cell homeostasis
GO:0033077T cell differentiation in thymus
GO:0006914autophagy
GO:0010507negative regulation of autophagy
GO:0006974DNA damage response
Gene Ontology - Molecular Function (Total: 11)
GO IDTerm
GO:0051434BH3 domain binding
GO:0042802identical protein binding
GO:0046982protein heterodimerization activity
GO:0002020protease binding
GO:0031625ubiquitin protein ligase binding
GO:0015267channel activity
GO:0016248channel inhibitor activity
GO:0043565sequence-specific DNA binding
GO:0051721protein phosphatase 2A binding
GO:0060090molecular adaptor activity
GO:0140297DNA-binding transcription factor binding
Gene Ontology - Cellular Component (Total: 14)
GO IDTerm
GO:0005741mitochondrial outer membrane
GO:0005739mitochondrion
GO:0005789endoplasmic reticulum membrane
GO:0005783endoplasmic reticulum
GO:0031965nuclear membrane
GO:0005634nucleus
GO:0005737cytoplasm
GO:0005829cytosol
GO:0016020membrane
GO:0032991protein-containing complex
GO:0043209myelin sheath
GO:0046930pore complex
GO:0097138BAD-BCL-2 complex
GO:0097148BCL-2 complex

Section 8: Protein Interactions & Molecular Networks STRING Interactions (Total: 7,722) Top 50 Highest-Confidence Interacting Proteins:

UniProtGeneInteraction Score
O43521BCL2L11999
P04637TP53999
Q14457BECN1999
Q12983BNIP3998
Q13794PMAIP1997
O00198HRK996
P21796VDAC1995
Q13323BIK995
Q96LC9BMF995
Q96PG8CREB3L2994
Q14643ITPR1993
Q99933BAK1993
O14727APAF1992
O60238BMI1992
Q14573ITPR3992
A8MW95BOK990
Q7L3V2CREB3L4989
Q12988HSPB3988
O94817ATG12986
P22736NR4A1985
Q07817BCL2L1984
O95817BAG3982
Q9C000NLRP1982
P42574CASP3980
Q14318FKBP8979
P00441SOD1977
Q8NEB9PIK3C3976
Q13625TP53BP2975
Q9P2Y5ULK1974
P00001(gene)972
P55269BAD972
Q16611BAK1969
P24385CCND1958
Q12982BNIP2955
Q14790CASP8955
Q00987MDM2953
O95140MFN2943
P01106MYC938
P01112HRAS938
P55211CASP9938
P31749AKT1934
P98170XIAP933
Q9C0C7AMBRA1931
Q6ZNE5C18orf8929
P05412JUN927
Q92934BAD926
Q9NYF8BCLAF1926
P0DP08CALM2921
P55957BID921
P17931LGALS3915
IntAct Physical Interactions (Total: 217) Key Direct Interactions (High Confidence):
Partner GeneInteraction TypeConfidence
BCL2L11 (BIM)direct interaction0.93
BAXphysical association0.95
BECN1physical association0.95
BIDdirect interaction0.87
BIKdirect interaction0.86
BADphysical association0.85
BBC3 (PUMA)direct interaction0.82
NLRP1physical association0.75
NR4A1direct interaction0.67
BMFdirect interaction0.62
BAK1direct interaction0.61
APPphysical association0.56
SOD1physical association0.56
PMAIP1 (NOXA)physical association0.52
SPNS1physical association0.46
ESM2 Structural Similarity (Total: 17 proteins)
UniProtTop SimilarityAverage Similarity
Q16611 (BAK1)0.99050.9719
Q6R755 (BCL2 - chimp)0.99980.9673
Q9JJV8 (BCL2 - mouse)0.99980.9668
P10417 (BCL2L1)0.99920.9668
P49950 (BCL2L1 - mouse)0.99930.9670
Q00709 (MCL1)0.99670.9669
O35425 (BCL2 - rat)1.00000.9500
Q792S6 (BCL2 - cow)1.00000.9500
DIAMOND Sequence Similarity (Total: 25 proteins)
UniProtSpecies/GeneTop IdentityBitscore
Q6R755BCL2 (chimp)97.90%478
Q9JJV8Bcl2 (mouse)97.90%478
P10417BCL2L196.60%473
P49950Bcl2l1 (mouse)96.60%469
Q64373Bcl2 (rat)99.60%466
P53563BCL2 (pig)99.60%465
Q07817BCL2L197.90%460
O77737BCL2 (macaque)97.90%459
O02718BCL2 (rabbit)87.40%412
Q1RMX3BCL2100.00%389
Q45T69BCL2100.00%389
Q92843BCL2L299.50%388
Q07813BCL2A199.00%382
Q63690Bcl2a1 (rat)99.00%382
O02703BCL2 (goat)97.40%378
Q07812BAX97.40%378
P70345Bcl2l10 (mouse)99.00%387
Q07818BCL2A198.90%365
Q07816BAK174.70%358
Q00709MCL171.50%344

Section 9: Transcription Factor Regulatory Data Note: BCL2 is NOT a transcription factor, but it is regulated by many TFs. Upstream Transcriptional Regulators of BCL2 (Total: 164) Activators (High Confidence):

TFRegulationConfidence
AP1ActivationHigh
ATF5ActivationHigh
BCL3ActivationHigh
CREB1ActivationHigh
CTNNB1ActivationHigh
E2F1ActivationHigh
ESR1ActivationHigh
FOSActivationHigh
GLI1ActivationHigh
GLI2ActivationHigh
LEF1ActivationHigh
MITFActivationHigh
MYBActivationHigh
NFKB1ActivationHigh
NFKBActivationHigh
NOTCH1ActivationHigh
Repressors (High Confidence):
TFRegulationConfidence
CEBPARepressionHigh
CREMRepressionHigh
FOXA1RepressionHigh
IRF1RepressionHigh
IRF8RepressionHigh
MAFRepressionHigh
NKX3-1RepressionHigh
PARP1RepressionHigh
PAX5Repression-
Mixed/Unknown Regulation (High Confidence):
TFRegulationConfidence
ARUnknownHigh
ATF1UnknownHigh
ATF2UnknownHigh
BACH2UnknownHigh
BCL6UnknownHigh
CEBPBUnknownHigh
EGR1UnknownHigh
GATA4UnknownHigh
GLI3UnknownHigh
IKZF3UnknownHigh
MYCUnknownHigh
NR2C2UnknownHigh

Section 10: Drug & Pharmacology Data ChEMBL Drug Targets for BCL2

Target IDTarget NameType
CHEMBL4860Apoptosis regulator Bcl-2SINGLE PROTEIN
CHEMBL3885513BAX/Bcl-2PROTEIN-PROTEIN INTERACTION
CHEMBL3885516Bcl-2/BAKPROTEIN-PROTEIN INTERACTION
CHEMBL4523685Cereblon/Bcl-2PROTEIN-PROTEIN INTERACTION
CHEMBL4748224VHL/Bcl-2PROTEIN-PROTEIN INTERACTION
CHEMBL5169264BCL2/BCL2L11PROTEIN-PROTEIN INTERACTION
CHEMBL5169265BCL2/BIDPROTEIN-PROTEIN INTERACTION
CHEMBL5169266BCL2/BADPROTEIN-PROTEIN INTERACTION
CHEMBL6066579Bcl-2/Beclin-1PROTEIN COMPLEX
Molecules Targeting BCL2 - Phase 3+ (Total: 7)
ChEMBL IDNameTypeHighest Phase
CHEMBL3137309VENETOCLAXSmall molecule4 (Approved)
CHEMBL1201752IXABEPILONESmall molecule4 (Approved)
CHEMBL443684NAVITOCLAXSmall molecule3
CHEMBL5314951SONROTOCLAXSmall molecule3
CHEMBL408194OBATOCLAXSmall molecule3
CHEMBL51483GOSSYPOLSmall molecule3
CHEMBL297453EPIGALOCATECHIN GALLATESmall molecule3
Venetoclax (ABT-199) - Key Drug Details
AttributeValue
ChEMBL IDCHEMBL3137309
Trade NamesVenclexta, Venclyxto
Other NamesABT-199, GDC-0199, RG-7601
ATC ClassificationL01XX52
TypeSmall molecule
Development Phase4 (Approved)
Clinical Trials613
Approved/Investigated Indications:
  • Chronic lymphocytic leukemia (Phase 4 - Approved)
  • Acute myeloid leukemia (Phase 4 - Approved)
  • Multiple myeloma (Phase 3)
  • Myelodysplastic syndrome (Phase 3)
  • Non-Hodgkin lymphoma (Phase 3)
  • Follicular lymphoma (Phase 2)
  • Mantle cell lymphoma (Phase 2)
  • Diffuse large B-cell lymphoma (Phase 2)
  • Waldenstrom macroglobulinemia (Phase 2)
  • T-cell lymphoma (Phase 2) PharmGKB Drug-Gene Associations
DrugClinical AnnotationsVariant Annotations
Carboplatin65134
Docetaxel81247
Paclitaxel45242
Ribavirin46346
Vincristine23179
Interferons109564
Polatuzumab vedotin00

Section 11: Expression Profiles Bgee Expression Summary

AttributeValue
GeneBCL2 (ENSG00000171791)
SpeciesHomo sapiens
Expression BreadthUbiquitous
Total Present Calls275
Max Expression Score96.44
Tissue Expression (Sample from 100+ tissues)
UBERON IDTissue/Structure
UBERON:0002106spleen
UBERON:0002370thymus
UBERON:0002371bone marrow
UBERON:0000029lymph node
UBERON:0002372tonsil
UBERON:0001987placenta
UBERON:0000992ovary
UBERON:0000995uterus
UBERON:0001295endometrium
UBERON:0002113kidney
UBERON:0001225cortex of kidney
UBERON:0000362renal medulla
UBERON:0002046thyroid gland
UBERON:0001911mammary gland
UBERON:0001896medulla oblongata
UBERON:0002038substantia nigra
UBERON:0003881CA1 field of hippocampus
UBERON:0002336corpus callosum
UBERON:0001630muscle organ
UBERON:0001134skeletal muscle tissue
UBERON:0001379vastus lateralis
UBERON:0001388gastrocnemius
UBERON:0001507biceps brachii
UBERON:0001013adipose tissue
UBERON:0002190subcutaneous adipose tissue
UBERON:0000178blood
UBERON:0000044dorsal root ganglion
UBERON:0001675trigeminal ganglion
UBERON:0002691ventral tegmental area
Single-Cell Expression Datasets (Total: 3)
Experiment IDDescriptionCells
E-ANND-2GTEx: snRNAseq atlas209,126
E-CURD-85T cells (blood, synovial fluid, tissue) in psoriatic arthritis111,869
E-GEOD-75688Primary breast cancer cells (4 subtypes)549

Section 12: Disease Associations Mendelian/Monogenic Disease Links

Disease IDDisease NameEvidence
MONDO:0018906Follicular lymphomaPrimary association
Follicular Lymphoma Details:
  • Synonyms: Follicle center lymphoma, follicular non-Hodgkin lymphoma
  • Associated genes: 4 (including BCL2)
  • Clinical trials: 524
  • Phenotypes: 17 Orphanet Disease Associations (Total: 3)
Orphanet IDDisease NameTypeGene Count
545Follicular lymphomaDisease4
480541High grade B-cell lymphoma with MYC/BCL2/BCL6 rearrangementDisease3
98839Intravascular large B-cell lymphomaDisease2
HPO Phenotype Associations (Total: 17)
HPO IDPhenotype
HP:0002665Lymphoma
HP:0002716Lymphadenopathy
HP:0100721Mediastinal lymphadenopathy
HP:0033823Mediastinal mass
HP:0001744Splenomegaly
HP:0001824Weight loss
HP:0001945Fever
HP:0030166Night sweats
HP:0012378Fatigue
HP:0002202Pleural effusion
HP:0001541Ascites
HP:0001004Lymphedema
HP:0001287Meningitis
HP:0002585Abnormal peritoneum morphology
HP:0003072Hypercalcemia
HP:0025435Increased circulating lactate dehydrogenase concentration
HP:0200036Skin nodule
GWAS Associations (Total: 108) Top 30 GWAS Trait Associations:
Study IDTraitP-value
GCST90002381Eosinophil count1.0e-85
GCST90002400Plateletcrit4.0e-76
GCST90002393Monocyte count4.0e-67
GCST90002382Eosinophil percentage of white cells2.0e-66
GCST90002379Basophil count2.0e-57
GCST90002390Mean corpuscular hemoglobin1.0e-51
GCST004618White blood cell count (basophil)1.0e-51
GCST90002392Mean corpuscular volume3.0e-48
GCST90002396Mean reticulocyte volume1.0e-43
GCST90002380Basophil percentage of white cells1.0e-39
GCST90002403Red blood cell count1.0e-36
GCST90002395Mean platelet volume4.0e-35
GCST009067Mosaic loss of chromosome Y1.0e-33
GCST90002397Mean spheric corpuscular volume1.0e-31
GCST90002394Monocyte percentage of white cells1.0e-28
GCST004606Eosinophil count7.0e-25
GCST90002402Platelet count4.0e-25
GCST90013663Alanine aminotransferase levels2.0e-22
GCST90002407White blood cell count4.0e-21
GCST90002382Eosinophil percentage6.0e-22
GCST004600Eosinophil percentage of white cells2.0e-20
GCST90002405Reticulocyte count2.0e-15
GCST006624Systolic blood pressure4.0e-15
GCST90020024A body shape index1.0e-14
GCST90002388Lymphocyte count7.0e-15
GCST006979Heel bone mineral density4.0e-14
GCST004599Mean platelet volume8.0e-14
GCST90011898Alanine aminotransferase levels5.0e-13
GCST003128Adolescent idiopathic scoliosis2.0e-12
GCST002073Chronic lymphocytic leukemia3.0e-12
Cancer-Related GWAS:
Study IDCancer/TraitP-value
GCST002073Chronic lymphocytic leukemia3.0e-12
GCST003468Chronic lymphocytic leukemia4.0e-11
GCST004146Chronic lymphocytic leukemia2.0e-11
GCST002643Follicular lymphoma8.0e-10
GCST006085Prostate cancer1.0e-08
QUICK REFERENCE SUMMARY
CategoryKey Identifier
HGNCHGNC:990
Ensembl GeneENSG00000171791
Entrez Gene596
OMIM151430
UniProt (Canonical)P10415
RefSeq mRNA (MANE)NM_000633
RefSeq ProteinNP_000624
Chromosome18q21.33
Genomic Positionchr18:63,123,346-63,320,128 (-)
Protein Length239 amino acids
Primary DiseaseFollicular lymphoma
Approved DrugVenetoclax (CHEMBL3137309)
Key FunctionAnti-apoptotic regulator
---Reference compiled from: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, SpliceAI, AlphaMissense, Reactome, Gene Ontology, STRING, IntAct, ChEMBL, PharmGKB, Bgee, GWAS Catalog, Orphanet, HPO, MONDO